期刊文献+

甘露醇、能量合剂联合抗癫痫药治疗发作频繁的小儿难治性癫痫的疗效 被引量:3

Mannitol,energy mixture with antiepileptic drug therapy attacks frequently the curative effect of children with intractable epilepsy
下载PDF
导出
摘要 目的:有效缓解小儿难治性癫痫发病症状,临床探究在使用抗癫痫药治疗同时加以甘露醇、能量合剂的效果。方法:选取我院2014年7月~2015年8月96例经诊断为难治性癫痫入院治疗的小儿患者,分为单一组、联合组,按挂号单双数进行分配,每组48例。单一组仅使用抗癫痫药,联合组在单一组用药基础上加用能量合剂以及甘露醇,观察两组疗效以及治疗前后发病次数。结果:联合组临床有效率高达91.7%,单一组仅为79.2%,联合组较单一组疗效好,P〈0.05;治疗前两组癫痫发病次数差异无统计学意义,P〉0.05,治疗后两组发病次数均有明显减少,联合组较单一组发病次数少,P〈0.05。结论:临床在治疗小儿难治性癫痫时在使用抗癫痫药同时加以甘露醇、能量合剂辅助治疗,患儿发病次数减少,恢复情况好,疗效高。 Objective:to effectively alleviate the symptoms in patients with refractory epilepsy children,in the use of antiepileptic drugs for clinical inquiry at the same time,the effect of mannitol and energy mixture. Methods:select our hospital during 2014.7~2015.8,96 cases diagnosed as intractable epilepsy hospitalized pediatric patients,divided into a single group,the joint group,according to the registered number of single and double,48 cases in each group. A single set of only the use of antiepileptic drugs,joint group on the basis of a single set of drug use and with energy mixture and mannitol,observe two groups of curative effect and the number of before and after treatment. Joint group clinical efficiency is as high as 91.7% as a result,a single set of only 79.2%,joint good curative effect in the single group,P 0.05; Two groups before treatment epilepsy frequency difference is meaningless,P 0.05,the number of two groups were significantly reduced after treatment,and less than the number of a single set of joint group,P0.05. Conclusion:clinical pediatric patients in the treatment of refractory epilepsy in the use of antiepileptic drugs to mannitol,energy mixture adjuvant therapy at the same time,the number of patients decreased,the recovery is good,high curative effect.
作者 石春林
出处 《北方药学》 2016年第4期23-24,共2页 Journal of North Pharmacy
关键词 疗效 癫痫 发病次数 抗癫痫药 难治性 甘露醇 能量合剂 小儿 Curative effect Epilepsy The number Antiepileptic drugs Refractory Mannitol.Energy mixture Pediatric
  • 相关文献

参考文献4

二级参考文献51

  • 1Vezzani A, French J, Bartfai T, et al. The role of inflammation in epilepsy [J]. Nat Rev Neurol, 2011, 7(1) : 31 -40.
  • 2Friedman A, Dingledine R. Molecular cascades that mediate the influence of inflammation on epilepsy [J]. Epilepsia, 2011, 52 Suppl 3 : 33 - 39.
  • 3Wei H, Zou H, Sheikh A M, et al. IL-6 is increased in the cerebellum of autistic brain and alters neural cell adhesion, migration and synaptic formation[J]. J Neuroinflammation, 2011, 8: 52.
  • 4McPherson C A, Aoyama M, Harry G J. Interleukin (IL)-1 and IL-6 regulation of neural progenitor cell proliferation with hippocampal injury: differential regulatory pathways in the subgranular zone (SGZ) of the adolescent and mature mouse brain [ J ]. Brain Behav Immun, 2011, 25(5) : 850 -862.
  • 5O'Reilly S, Ciechomska M, Cant R, et al. Interleukin-6, its role in fibrosing conditions [ J ]. Cytokine Growth Factor Rev, 2012 May 4. [Epub ahead of print].
  • 6Boulanger M J, Chow D C, Brevnova E E, et al. Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex [J]. Science, 2003, 300(5628): 2101 -2104.
  • 7Shu H F, Zhang C Q, Yin Q, et al. Expression of the iuterleukin 6 system in cortical lesions from patients with tuberous sclerosis complex and focal cortical dysplasia type Ⅱb [J]. J Neuropathol Exp Neurol, 2010, 69(8) : 838 -849.
  • 8Vezzani A, Friedman A. Brain inflammation as a biomarker in epilepsy [J]. BiomarkMed, 2011,5(5): 607 -614.
  • 9Anton K, Banerjee D, Glod J. Macrophage-associated mesenchymal stem cells assume an activated, migratory, pro-inflammatory pheno-type with increased IL45 and CXCL10 secretion [J]. PLoS One, 2012, 7(4) : e35036.
  • 10Drucker C, Gewiese J, Malchow S, et al. Impact of interleukin-6 classic- and trans-signaling on liver damage and regeneration [J]. J Autoimmun, 2010, 34(1): 29-37.

共引文献63

同被引文献36

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部